Order Article Reprints

Dobiáš R, Káňová M, Petejová N, Pisti ŠK, Bocek R, Krejčí E, Stružková H, Cachová M, Tomášková H, Hamal P, et al. Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients. Journal of Fungi. 2022; 8(3):308. https://doi.org/10.3390/jof8030308

Dobiáš, Radim, Marcela Káňová, Naděžda Petejová, Štefan Kis Pisti, Robert Bocek, Eva Krejčí, Helena Stružková, Michaela Cachová, Hana Tomášková, Petr Hamal, and et al. 2022. "Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients" Journal of Fungi 8, no. 3: 308. https://doi.org/10.3390/jof8030308

Dobiáš, R., Káňová, M., Petejová, N., Pisti, Š. K., Bocek, R., Krejčí, E., Stružková, H., Cachová, M., Tomášková, H., Hamal, P., Havlíček, V., & Raška, M. (2022). Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients. Journal of Fungi, 8(3), 308. https://doi.org/10.3390/jof8030308